神经毡蛋白及其配体的信号传导通路
Signal Transduction Pathways of Neuropilin and Its Ligands
DOI: 10.12677/ACM.2021.112106, PDF,   
作者: 吕 婷, 汤 蓉, 杨光路*:内蒙古医科大学,内蒙古 呼和浩特
关键词: 神经毡蛋白配体受体Neurotapetin NPN Receptor
摘要: 神经毡蛋白(Neuropilin, NPN/NRP)是分泌糖蛋白的细胞表面受体,为非酪氨酸激酶受体,有NPN1及NPN2两种亚型。NRPs最初分别通过介导3类信号素和血管内皮生长因子驱动的信号通路参与神经元引导、血管生成和胚胎血管生成的过程。除此之外,NPN目前已知的调节众多信号通路的配体还包括表皮生长因子(Epidermal growth factor, EGF),成纤维细胞生长因子(Fibroblast Growth Factors, FGF),血小板衍生生长因子(platelet-derived growth factor, PDGF)和转化生长因子-β (transforming growth factor-β, TGF-β)等。本文总结了NPN的相关配体,并对其信号传导通路作简单介绍,为NPN的研究提供新的思路。
Abstract: Neuropilin, NPN/NRP is a cell surface receptor that secretes glycoproteins and is a non-tyrosine kinase receptor. There are two subtypes of NPN1 and NPN2. NRPs initially participate in the process of neuron guidance, angiogenesis and embryonic angiogenesis by mediating three types of signal elements and vascular endothelial growth factor-driven signal pathways, respectively. In addition, the known ligands of NPN to regulate many signaling pathways include epidermal growth factor (EGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF) and transforming growth factor-β (TGF-β). In this paper, the related ligands of NPN are summarized, and their signal transduction pathways are briefly introduced, which provides a new idea for the study of NPN.
文章引用:吕婷, 汤蓉, 杨光路. 神经毡蛋白及其配体的信号传导通路[J]. 临床医学进展, 2021, 11(2): 744-748. https://doi.org/10.12677/ACM.2021.112106

参考文献

[1] 文思思. 神经纤毛蛋白及其配体的免疫调节机制[J]. 国际输血及血液学杂志, 2015, 38(2): 178-181.
[2] Gerstmann, K., Kindbeiter, K., Telley, L., Bozon, M., Charoy, C., Jabaudon, D., Moret, F. and Castellani, V. (2020) An Unconventional Cerebrospinal Fluid-Derived Semaphorin-Signalling Regulates Apical Progenitor Dynamics in the Developing Neocortex. [Google Scholar] [CrossRef
[3] Perez-Miller, S., et al. (2020) In Silico Identification and Validation of Inhibitors of the Interaction between Neuropilin Receptor 1 and SARS-CoV-2 Spike Protein.
[4] 高增法, 吴永娜, 杜海云, 李汛. 神经菌毛蛋白1的研究进展[J]. 基础医学与临床, 2016, 36(2): 258-261.
[5] Hosseinpour, M., Mashayekhi, F., Bidabadi, E. and Salehi, Z. (2017) Neuropilin-2 rs849563 Gene Variations and Susceptibility to Autism in Iranian Population: A Case-Control Study. Metabolic Brain Disease, 32, 1471-1474. [Google Scholar] [CrossRef] [PubMed]
[6] Gant, J.C., Thibault, O., Blalock, E.M., Yang, J., Bachstetter, A., Kotick, J., Schauwecker, P.E., Hauser, K.F., Smith, G.M., Mervis, R., Li, Y.F. and Barnes, G.N. (2009) Decreased Number of Interneurons and Increased Seizures in Neuropilin 2 Deficient Mice: Implications for Autism and Epilepsy. Epilepsia, 50, 629-645. [Google Scholar] [CrossRef] [PubMed]
[7] Valiulyte, I., et al. (2020) A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival. International Journal of Molecular Sciences, 21, 7396. [Google Scholar] [CrossRef] [PubMed]
[8] Zhu, E., Blom, D., Sethumadhavan, S., et al. (2020) 683 A Novel Mechanism of Neuropilin-1 Inhibition Results in Improved Tumor Growth Inhibition in Vivo. Journal for ImmunoTherapy of Cancer, 8, A722. [Google Scholar] [CrossRef
[9] Gerstmann, K., Kindbeiter, K., Telley, L., et al. (2020) An Unconventional Cerebrospinal Fluid-Derived Semaphorin-Signalling Regulates Apical Progenitor Dynamics in the Developing Neocortex.
[10] Wang, Q., Chiu, S.-L., Koropouli, E., et al. (2017) Neuropilin-2/PlexinA3 Receptors Associate with GluA1 and Mediate Sema3F-Dependent Homeostatic Scaling in Cortical Neurons. Neuron, 96, 1084-1098.e7. [Google Scholar] [CrossRef] [PubMed]
[11] Inokuchi, K., Imamura, F., Takeuchi, H., Kim, R., Okuno, H., Nishizumi, H., Bito, H., Kikusui, T. and Sakano, S. (2017) Nrp2 Is Sufficient to Instruct Circuit Formation of Mitral-Cells to Mediate Odour-Induced Attractive Social Responses. Nature Communications, 8, Article No. 15977. [Google Scholar] [CrossRef] [PubMed]
[12] Tan, C., Lu, N.-N., Wang, C.-K., et al. (2019) Endothelium-Derived Semaphorin 3G Regulates Hippocampal Synaptic Structure and Plasticity via Neuropilin-2/PlexinA4. Neuron, 101, 920-937.e13. [Google Scholar] [CrossRef] [PubMed]
[13] Gant, J.C., Oliver, T., BlalockEric, M., et al. (2009) Decreased Number of Interneurons and Increased Seizures in Neuropilin2 Deficient Mice: Implications for Autism and Epilepsy. Epilepsia, 50, 629-645. [Google Scholar] [CrossRef] [PubMed]
[14] Angelika, B., Michael, F., Martina, R., et al. (2019) Neuropilin-2 Is an Independent Prognostic Factor for Shorter Cancer-Specific Survival in Patients with Acinar Adenocarcinoma of the Prostate. International Journal of Cancer, 146, 2619-2627. [Google Scholar] [CrossRef] [PubMed]
[15] Harman, J.L., Sayers, J., Chapman, C., et al. (2020) Emerging Roles for Neuropilin-2 in Cardiovascular Disease. International Journal of Molecular Sciences, 21, 5154. [Google Scholar] [CrossRef] [PubMed]
[16] Elaimy, A.L., Amante, J.J., Zhu, L.J., Wang, M., Walmsley, C.S., FitzGerald, T.J., Goel, H.L. and Mercurio, A.M. (2019) The VEGF Receptor Neuropilin 2 Promotes Homologous Recombination by Stimulating YAP/TAZ-Mediated Rad51 Expression. Proceedings of the National Academy of Sciences of the United States of America, 116, 14174-14180. [Google Scholar] [CrossRef] [PubMed]
[17] Shen, J.K., Samul, R., Zimmer, J., Liu, H.S., Liang, X.L., Hackett, S. and Campochiaro, P.A. (2004) Deficiency of Neuropilin 2 Suppresses VEGF-Induced Retinal Neovascularization. Molecular Medicine, 10, 12-18. [Google Scholar] [CrossRef
[18] 刘想梅, 徐卫国. Neuropilins在肿瘤中的多功能作用机制[J]. 岭南现代临床外科, 2020, 20(4): 540-544.
[19] Xu, W.G., Yang, X., Zhan, Q.Q., Ding, G.Y., Guo, S., Zhu, B., Xu, H. and Liu, X.M. (2020) Silencing Neuropilin 1 Gene Reverses TGF-β1-Induced Epithelial Mesenchymal Transition in HGC-27 Gastric Cancer Cell Line. Oncology and Translational Medicine, 6, 258-265.
[20] McGowan, S.E. and McCoy, D.M. (2020) Neuropilin-1 Directs PDGFRα-Entry into Lung Fibroblasts and Signaling from Very Early Endosomes. American Journal of Physiology-Lung Cellular and Molecular Physiology. [Google Scholar] [CrossRef] [PubMed]
[21] Abdullah, A., et al. (2021) Epigenetic Targeting of Neuropilin-1 Prevents by Pass Signaling in Drug-Resistant Breast Cancer. Oncogene, 40, 322-333.